EULAR Corporate Members
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
| AbbVie Inc. |
| UCB BioPharma SRL |
| Pfizer Inc. |
| Janssen Pharmaceutica NV |
| Novartis Pharma AG |
| Eli Lilly and Company |
| AstraZeneca UK Ltd. |
| GlaxoSmithKline Research and Development Ltd. |
| Bristol-Myers Squibb |
| Galapagos NV |
| medac GmbH |
| Boehringer Ingelheim International GmbH |
| Amgen (Europe) GmbH |
| F. Hoffmann-La Roche Ltd. |
| Vifor Fresenius Medical Care Renal Pharma Ltd. |
| IBSA Institut Biochimique SA |
| Fresenius Kabi SwissBioSim |
| Celltrion Healthcare Co. Ltd. |
| Otsuka Pharmaceutical Europe Ltd. |
| Biogen International GmbH |
| Merck Healthcare KGaA |
| Gilead Sciences Europe Ltd. |
Related Information
Application Form
EULAR Corporate membership application form
The EULAR Family
A presentation of the EULAR member organisations.
EULAR Governance
EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.
EULAR Communities
EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs.
EULAR comprises the HPR, PARE and EMEUNET communities, which include 105 member societies / organisations, working on a variety of activities supporting EULAR objectives.